US Bancorp’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.23K | Sell |
318
-488
| -61% | -$11.9K | ﹤0.01% | 3511 |
|
|
2025
Q4 | $21.6K | Sell |
806
-44
| -5% | -$1.13K | ﹤0.01% | 3051 |
|
|
2025
Q3 | $22.7K | Buy |
850
+419
| +97% | +$10.8K | ﹤0.01% | 3022 |
|
|
2025
Q2 | $9.9K | Buy |
431
+29
| +7% | +$720 | ﹤0.01% | 3427 |
|
|
2025
Q1 | $11.7K | Sell |
402
-446
| -53% | -$14.2K | ﹤0.01% | 3383 |
|
|
2024
Q4 | $31.5K | Sell |
848
-6,520
| -88% | -$298K | ﹤0.01% | 2958 |
|
|
2024
Q3 | $358K | Sell |
7,368
-6,986
| -49% | -$307K | ﹤0.01% | 1708 |
|
|
2024
Q2 | $574K | Sell |
14,354
-2,702
| -16% | -$112K | ﹤0.01% | 1396 |
|
|
2024
Q1 | $749K | Sell |
17,056
-4,192
| -20% | -$217K | ﹤0.01% | 1263 |
|
|
2023
Q4 | $1.31M | Buy |
21,248
+20,475
| +2,649% | +$1.08M | ﹤0.01% | 1002 |
|
|
2023
Q3 | $35.5K | Sell |
773
-308
| -28% | -$16.8K | ﹤0.01% | 2602 |
|
|
2023
Q2 | $62.1K | Sell |
1,081
-2,277
| -68% | -$101K | ﹤0.01% | 2408 |
|
|
2023
Q1 | $126K | Buy |
3,358
+58
| +2% | +$1.9K | ﹤0.01% | 2077 |
|
|
2022
Q4 | $92.5K | Buy |
3,300
+808
| +32% | +$23.5K | ﹤0.01% | 2236 |
|
|
2022
Q3 | $70K | Buy |
2,492
+469
| +23% | +$15.3K | ﹤0.01% | 2353 |
|
|
2022
Q2 | $70K | Buy |
2,023
+670
| +50% | +$23.9K | ﹤0.01% | 2410 |
|
|
2022
Q1 | $49K | Buy |
1,353
+43
| +3% | +$1.22K | ﹤0.01% | 2632 |
|
|
2021
Q4 | $31K | Buy |
1,310
+149
| +13% | +$3.05K | ﹤0.01% | 2879 |
|
|
2021
Q3 | $22K | Hold |
1,161
| – | – | ﹤0.01% | 3072 |
|
|
2021
Q2 | $23K | Hold |
1,161
| – | – | ﹤0.01% | 3052 |
|
|
2021
Q1 | $21K | Sell |
1,161
-31
| -3% | -$576 | ﹤0.01% | 2994 |
|
|
2020
Q4 | $24K | Hold |
1,192
| – | – | ﹤0.01% | 2831 |
|
|
2020
Q3 | $23K | Sell |
1,192
-2,102
| -64% | -$42.3K | ﹤0.01% | 2751 |
|
|
2020
Q2 | $74K | Buy |
3,294
+2,133
| +184% | +$39.1K | ﹤0.01% | 2244 |
|
|
2020
Q1 | $17K | Sell |
1,161
-237
| -17% | -$4.12K | ﹤0.01% | 2819 |
|
|
2019
Q4 | $27K | Buy |
+1,398
| New | +$26.8K | ﹤0.01% | 2751 |
|
|
2019
Q2 | – | Sell |
-140
| Closed | -$3K | – | 3607 |
|
|
2019
Q1 | $3K | Buy |
+140
| New | +$3.14K | ﹤0.01% | 3329 |
|
|
2015
Q3 | – | Sell |
-9,055
| Closed | -$159K | – | 3572 |
|
|
2015
Q2 | $159K | Sell |
9,055
-340
| -4% | -$5.3K | ﹤0.01% | 1871 |
|
|
2015
Q1 | $141K | Sell |
9,395
-665
| -7% | -$8.89K | ﹤0.01% | 1947 |
|
|
2014
Q4 | $117K | Buy |
+10,060
| New | +$110K | ﹤0.01% | 2046 |
|
Other funds holding AMPH
VCM
BTW
US Bancorp's AMPH Position: Q1 2026 in Review
US Bancorp reduced its Amphastar Pharmaceuticals (AMPH) stake by 61% in Q1 2026, selling an estimated $11.9K and leaving 318 shares worth $6.23K. The position accounts for ﹤0.01% of the portfolio, ranked #3511.
US Bancorp first reported a position in AMPH in Q4 2014 and has held it in 30 quarters since. The position peaked at $1.31M in Q4 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- US Bancorp held 318 shares of Amphastar Pharmaceuticals worth $6.23K as of Q1 2026.
- US Bancorp sold 488 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $11.9K.
- Amphastar Pharmaceuticals made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3511 holding.
- US Bancorp first reported a position in Amphastar Pharmaceuticals in Q4 2014 and has held it in 30 quarters since.
- US Bancorp's Amphastar Pharmaceuticals position peaked at $1.31M in Q4 2023.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.